TIBSOVO is a targeted therapy that works against an abnormal protein created by a mutation in the IDH1 gene. This abnormal ...

We tend to overlook some bodily conditions and brush them off as nothing serious. However, a doctor’s visit may reveal a more ...

AbbVie today announced it will unveil new data at the 2025 American Society of Hematology (ASH) Congress, showcasing continued advances in research across multiple blood cancers including ? multiple ...